+48.7%
CVS vs RCAT
-99.9%
+148.5%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.0% | -7.5% | +8.5% | +1.0% |
| 7D | -9.5% | -52.8% | +43.2% | -9.3% |
| 30D | -12.9% | -60.8% | +47.9% | -12.6% |
| 3M | -13.1% | -81.2% | +68.1% | -12.6% |
| 6M | -12.2% | -79.9% | +67.7% | -11.8% |
| YTD | +5.0% | -77.4% | +82.4% | +5.3% |
| 1Y | +9.6% | -70.8% | +80.3% | +9.8% |
| 3Y | +32.6% | +99.4% | -66.8% | +31.4% |
| 5Y | +2.6% | -24.6% | +27.1% | +1.7% |
| All | +48.7% | -99.9% | +148.5% | +42.2% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling